11
Phase 2–4 trials
GLP-1 & incretin therapies · Live ClinicalTrials.gov data
Survodutide clinical trial pipeline
ClinicalTrials.gov lists 11 phase 2–4 trials for survodutide, 2 of them actively recruiting. The next phase 3 primary completion among them is expected Jun 2029. Refreshed daily — add up to four competitors to compare pipelines side by side.
8
Phase 3 trials
2
Actively recruiting
Jun 2029
Next phase 3 primary completion
12,003
Participants across trials
Boehringer Ingelheim
Lead sponsor by trial count
survodutide (11)3 active2021–2033
survodutide
'21
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
'32
'33
survodutide
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose WeightP2
A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)P2
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)P3
SYNCHRONIZE™-1P3
SYNCHRONIZE™-2P3
SYNCHRONIZE™JPP3
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose WeightP3
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)P3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisP3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisP3
ARTIST-CKDP2
Upcoming readouts
3 ahead · survodutide
Select a trial to load its full ClinicalTrials.gov record.
Key survodutide trials
Top 11 of the 11 registered phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06632457 | LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH … | Phase 3 | Recruiting | Jun 2029 |
| NCT06632444 | LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Mod… | Phase 3 | Recruiting | Dec 2031 |
| NCT06214741 | A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose… | Phase 3 | Completed | Jul 2025 |
| NCT06309992 | A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Pre… | Phase 3 | Completed | Oct 2025 |
| NCT06066515 | SYNCHRONIZE™-1 — A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have… | Phase 3 | Completed | Dec 2025 |
| NCT06176365 | SYNCHRONIZE™JP — A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease | Phase 3 | Completed | Dec 2025 |
| NCT06066528 | SYNCHRONIZE™-2 — A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have D… | Phase 3 | Completed | Dec 2025 |
| NCT06077864 | A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Ob… | Phase 3 | Completed | Jun 2026 |
| NCT07206290 | ARTIST-CKD — Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease | Phase 2 | Not yet recruiting | Nov 2027 |
| NCT04667377 | A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight | Phase 2 | Completed | Sept 2022 |
| NCT04771273 | A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NA… | Phase 2 | Completed | Nov 2023 |
Related drug pipelines
FAQ
- How many clinical trials are running for survodutide?
- ClinicalTrials.gov currently lists 11 phase 2–4 survodutide trials: 3 phase 2, 8 phase 3, and 0 phase 4. 2 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare survodutide against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.